IFNA1 and hepatocellular carcinoma: To confirm whether IGFBP7 expression is associated with the clinical response to IFN-α/5-FU therapy, HCC samples of 30 patients who underwent IFN-α/5-FU therapy postoperatively were immunohistochemically stained for IGFBP7 expression.